Pharmacological evaluation of ashwagandha root extract in rat model of the metabolic syndrome

Abstract

Medicinal plants hold significant pharmaceutical and therapeutic potential, offering promising avenues for novel product development beneficial to human health. Herbs have played a vital role in healthcare systems globally, serving as effective remedies for preventing and managing various health conditions. In the present study, the pharmacological effects of the root extract of Withania somnifera (Ashwagandha) were evaluated, with a special focus on its role in managing metabolic syndrome using a rat model. The research emphasized assessing parameters such as antihyperglycemic, antihyperlipidemic, anti-inflammatory, and antioxidant effects to understand the therapeutic potential of the extract. The results suggest that Ashwagandha root extract exhibits considerable efficacy in ameliorating metabolic syndrome-related symptoms with minimal side effects. These findings highlight the plant’s potential for incorporation into formulations aimed at addressing metabolic disorders. Further studies should aim to explore broader pharmacological activities, including cardiovascular and neuroprotective effects, to establish its utility in diverse clinical applications.